封面
市場調查報告書
商品編碼
1671006

2025年血管栓塞全球市場報告

Vascular Embolization Global Market Report 2025

出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年血管栓塞市場規模將強勁成長。到 2029 年,這一數字將成長至 49.1 億美元,複合年成長率為 9.6%。預測期內的成長可歸因於慢性疾病患者數量的增加、研發活動投資的增加、對微創手術的偏好日益增加、地域擴張和醫療保健的可及性以及可支配收入的增加。預測期內的關鍵趨勢包括技術進步、策略聯盟、策略合作夥伴關係以及創新血管栓塞裝置的開發。

血管疾病盛行率的不斷上升預計將推動血管栓塞市場的成長。血管疾病包括影響血管(如動脈和靜脈)的各種疾病,導致血流量減少和各種狀況,包括周邊血管疾病、腹部主動脈血管瘤、深層靜脈栓塞症、動脈粥狀硬化、慢性靜脈功能不全和周邊動脈疾病。血管栓塞是治療這些疾病的方法,可解決與血管阻塞和阻塞相關的出血、修復動脈瘤並改善靜脈血液供應。截至 2023 年 4 月,HMP Communications LLC 預測 2020 年全球周邊動脈疾病(PAD) 盛行率為 2,100 萬例,到 2030 年將達到 2,380 萬例。這顯示血管疾病盛行率的上升是血管栓塞市場的主要促進因素。

慢性腎臟病的高盛行率預計將推動血管栓塞市場的未來成長。慢性腎臟病(CKD) 是一種以腎臟隨著時間的推移逐漸受到不可逆轉的損害為特徵的疾病。血管栓塞用於 CKD 控制腎腫瘤、動靜脈畸形 (AVM) 出血以及切片檢查和移植併發症,並可避免開放性手術相關的風險,特別是對於腎功能受損的患者。例如,英國腎臟研究委員會ZS Associates的一份報告預測,到2023年,英國腎臟病的患病人數將達到719萬人,佔總人口的10%多一點;到2033年,這一數字將上升到761萬人,晚期患者的比例將從45%上升到51%。因此,慢性腎臟病盛行率的上升正在推動血管栓塞市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場:宏觀經濟情景,包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球血管栓塞PESTEL分析(政治、社會、技術、環境、法律、促進因素、限制因素)
  • 最終用途產業分析
  • 全球血管栓塞市場:成長率分析
  • 全球血管栓塞市場表現:規模與成長,2019-2024
  • 全球血管栓塞市場預測:規模與成長,2024-2029 年,2034 年
  • 血管栓塞的全球總體目標市場(TAM)

第6章市場區隔

  • 全球血管栓塞市場:依產品、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 栓塞劑
  • 栓塞裝置
  • 全球血管栓塞市場(按栓塞類型、實際數據和預測),2019-2024 年、2024-2029 年、2034 年
  • 線圈裝置
  • 非線圈設備
  • 全球血管栓塞市場:應用、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 周邊血管疾病
  • 腫瘤學
  • 泌尿系統
  • 神經病學
  • 其他用途
  • 全球血管栓塞市場:按最終用戶、績效和預測,2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 專科診所
  • 門診手術中心
  • 診斷中心
  • 全球血管栓塞市場按栓塞劑類型、性能和預測進行細分,2019-2024 年、2024-2029 年、2034 年
  • 顆粒栓塞劑
  • 液態栓塞劑
  • 線圈栓塞劑
  • 明膠海綿栓塞劑
  • 全球血管栓塞市場,按栓塞裝置類型細分,性能和預測,2019-2024 年、2024-2029 年、2034 年
  • 球囊阻塞設備
  • 導管
  • 凝血酶注射系統

第7章 區域和國家分析

  • 全球血管栓塞市場:按地區、績效及預測,2019-2024 年、2024-2029 年、2034 年
  • 全球血管栓塞市場:依國家、表現及預測,2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章:中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章:義大利市場

第20章:西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章:加拿大市場

第26章 南美洲市場

第27章:巴西市場

第28章 中東市場

第29章:非洲市場

第30章競爭格局與公司概況

  • 血管栓塞市場:競爭格局
  • 血管栓塞市場:公司簡介
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
    • Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • B. Braun Melsungen AG
  • Kaneka Corporation
  • Terumo Corporation
  • WL Gore & Associates Inc.
  • Teleflex Inc.
  • Cook Group Incorporated
  • Merit Medical Systems Inc.
  • Penumbra Inc.
  • MicroPort Scientific Corporation
  • MicroVention Inc.
  • Medikit Co Ltd.
  • Silk Road Medical Inc.
  • Galt Medical Corporation
  • Neuravi Ltd.
  • Phenox GmbH

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年血管栓塞市場:提供新機會的國家
  • 2029年血管栓塞市場:細分領域帶來新機會
  • 2029年血管栓塞市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r25377

Vascular embolization is a minimally invasive procedure that utilizes different materials, including coils, particles, or liquid agents, to block or impede blood vessels, thereby halting arterial bleeding. This technique is employed for various purposes, such as treating malignancies, shrinking vascular abnormalities, or redirecting blood flow.

The main products associated with vascular embolization are embolic agents and embolization devices. Embolic agents are chemicals or materials injected or placed in specific regions to block or occlude blood vessels, effectively treating various medical conditions. These agents are utilized in different procedures to address medical issues such as tumors, aneurysms, and arteriovenous malformations (AVMs). Various embolization techniques include coiling devices and non-coiling devices, applied in diverse medical applications such as peripheral vascular diseases, oncology, urology, neurology, and others. These products cater to various end-users, including hospitals, specialty clinics, ambulatory surgical centers, and diagnostic centers.

The vascular embolization market research report is one of a series of new reports from The Business Research Company that provides vascular embolization market statistics, including vascular embolization industry global market size, regional shares, competitors with a vascular embolization market share, detailed vascular embolization market segments, market trends and opportunities, and any further data you may need to thrive in the vascular embolization industry. This vascular embolization market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vascular embolization market size has grown strongly in recent years. It will grow from $3.15 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rising prevalence of vascular diseases, rise in demand for non-coiling devices, surge in the use of clot agents, increased awareness about advanced treatment options

The vascular embolization market size is expected to see strong growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to growth in the cases of chronic diseases, rising investments in r&d activities, growing preference for minimally invasive procedures, geographic expansion and access to healthcare, rising disposable incomes. Major trends in the forecast period include technological advancements, strategic collaborations, strategic collaborations, development of innovative vascular embolization devices.

The anticipated rise in the prevalence of vascular diseases is set to drive the growth of the vascular embolization market. Vascular diseases encompass various disorders affecting blood vessels, including arteries and veins, leading to reduced blood flow and various conditions such as peripheral vascular disease, abdominal aortic aneurysm, deep vein thrombosis, atherosclerosis, chronic venous insufficiency, and peripheral artery diseases. Vascular embolization serves as a treatment for these disorders, involving the occlusion or obstruction of blood vessels to address bleeding, repair aneurysms, and enhance blood supply in veins. As of April 2023, HMP Communications LLC reported a global prevalence of 21 million cases of peripheral artery diseases (PAD) in 2020, projected to reach 23.8 million by 2030. This underlines how the increasing prevalence of vascular diseases is a key driver for the vascular embolization market.

The high prevalence of chronic kidney diseases is expected to drive the growth of the vascular embolization market in the future. Chronic Kidney Disease (CKD) is a condition characterized by the gradual and irreversible damage to the kidneys over time. Vascular embolization can be employed in CKD to control bleeding from kidney tumors, arteriovenous malformations (AVMs), or complications arising from kidney biopsies or transplants, thereby avoiding the risks associated with open surgery, particularly for patients with compromised kidney function. For example, a report by ZS Associates, a UK-based Kidney Research Commission, indicated that the prevalence of kidney disease in the UK was estimated to affect 7.19 million people in 2023, over 10% of the population, and is projected to rise to 7.61 million by 2033, with the percentage of patients in later stages of the disease increasing from 45% to 51%. Thus, the rising prevalence of chronic kidney diseases is propelling the growth of the vascular embolization market.

A prominent trend in the vascular embolization market is the adoption of technological advancements by major companies. These innovations are geared towards sustaining their market positions and enhancing the effectiveness of vascular embolization procedures. For example, in June 2022, India Medtronic Private Limited, a subsidiary of Medtronic plc, introduced the Pipeline Vantage, a flex embolization device designed for the treatment of brain aneurysms. This device incorporates shield technology and features improved delivery design characteristics, making it more reliable for clinicians to transport, deploy, and treat brain aneurysms.

Major companies in the vascular embolization market are focusing on developing innovative products such as embolic systems to drive profitability. Embolic systems, comprising embolic agents and delivery devices, are utilized to intentionally block blood vessels in medical procedures. In October 2023, Sirtex Medical launched the Lava liquid embolic system (LES), offering a versatile solution for controlled target vessel occlusion in peripheral vasculature. Its varied viscosity options enable effective distal embolization of small and hard-to-reach vessels, providing physicians with enhanced treatment options.

In August 2022, Boston Scientific Corporation acquired Obsidio. This acquisition aims to expand Boston Scientific Corporation's interventional oncology and embolization portfolio, offering unique options for physicians and patients dealing with hemorrhages, cancer, and other debilitating conditions. Obsidio specializes in minimally invasive blood vessel occlusion.

Major companies operating in the vascular embolization market include Abbott Laboratories, Medtronic Plc., Merck Group, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Kaneka Corporation, Terumo Corporation, W. L. Gore & Associates Inc., Teleflex Inc., Cook Group Incorporated, Merit Medical Systems Inc., Penumbra Inc., MicroPort Scientific Corporation, MicroVention Inc., Medikit Co Ltd., Silk Road Medical Inc., Galt Medical Corporation, Neuravi Ltd., Phenox GmbH, Spartan Micro Inc., EndoShape Inc., Shape Memory Medical Inc., Balt Group, Vascular Solutions Inc.

North America was the largest region in the vascular embolization market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vascular embolization market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vascular embolization market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The vascular embolization market consists of revenues earned by entities by providing vascular embolization techniques such as chemoembolization or radioembolization, sac packing, sandwich technique, stent-assisted coiling, and particle embolization. The market value includes the value of related goods sold by the service provider or included within the service offering. The vascular embolization market also includes sales of balloons, gelatin foam, liquid glue, liquid sclerosing agents, particulate agents, detachable coils, and push able coils. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vascular Embolization Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vascular embolization market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vascular embolization ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vascular embolization market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Embolic Agents; Embolization Devices
  • 2) By Embolization Technique: Coiling Devices; Non-Coiling Devices
  • 3) By Application: Peripheral Vascular Diseases; Oncology; Urology; Neurology; Other Applications
  • 4) By End Users: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Diagnostic Centers
  • Subsegments:
  • 1) By Embolic Agents: Particle Embolic Agents; Liquid Embolic Agents; Coil Embolic Agents; Gelatin Sponge Embolic Agents
  • 2) By Embolization Devices: Balloon Occlusion Devices; Catheters; Thrombin Injection Systems
  • Companies Mentioned: Abbott Laboratories; Medtronic Plc.; Merck Group; Stryker Corporation; Boston Scientific Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vascular Embolization Market Characteristics

3. Vascular Embolization Market Trends And Strategies

4. Vascular Embolization Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Vascular Embolization Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Vascular Embolization PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Vascular Embolization Market Growth Rate Analysis
  • 5.4. Global Vascular Embolization Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Vascular Embolization Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Vascular Embolization Total Addressable Market (TAM)

6. Vascular Embolization Market Segmentation

  • 6.1. Global Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Embolic Agents
  • Embolization Devices
  • 6.2. Global Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Coiling Devices
  • Non-Coiling Devices
  • 6.3. Global Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Peripheral Vascular Diseases
  • Oncology
  • Urology
  • Neurology
  • Other Applications
  • 6.4. Global Vascular Embolization Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • 6.5. Global Vascular Embolization Market, Sub-Segmentation Of Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Particle Embolic Agents
  • Liquid Embolic Agents
  • Coil Embolic Agents
  • Gelatin Sponge Embolic Agents
  • 6.6. Global Vascular Embolization Market, Sub-Segmentation Of Embolization Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Balloon Occlusion Devices
  • Catheters
  • Thrombin Injection Systems

7. Vascular Embolization Market Regional And Country Analysis

  • 7.1. Global Vascular Embolization Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Vascular Embolization Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vascular Embolization Market

  • 8.1. Asia-Pacific Vascular Embolization Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vascular Embolization Market

  • 9.1. China Vascular Embolization Market Overview
  • 9.2. China Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vascular Embolization Market

  • 10.1. India Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vascular Embolization Market

  • 11.1. Japan Vascular Embolization Market Overview
  • 11.2. Japan Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vascular Embolization Market

  • 12.1. Australia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vascular Embolization Market

  • 13.1. Indonesia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vascular Embolization Market

  • 14.1. South Korea Vascular Embolization Market Overview
  • 14.2. South Korea Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vascular Embolization Market

  • 15.1. Western Europe Vascular Embolization Market Overview
  • 15.2. Western Europe Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vascular Embolization Market

  • 16.1. UK Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vascular Embolization Market

  • 17.1. Germany Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vascular Embolization Market

  • 18.1. France Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vascular Embolization Market

  • 19.1. Italy Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vascular Embolization Market

  • 20.1. Spain Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vascular Embolization Market

  • 21.1. Eastern Europe Vascular Embolization Market Overview
  • 21.2. Eastern Europe Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vascular Embolization Market

  • 22.1. Russia Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vascular Embolization Market

  • 23.1. North America Vascular Embolization Market Overview
  • 23.2. North America Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vascular Embolization Market

  • 24.1. USA Vascular Embolization Market Overview
  • 24.2. USA Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vascular Embolization Market

  • 25.1. Canada Vascular Embolization Market Overview
  • 25.2. Canada Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vascular Embolization Market

  • 26.1. South America Vascular Embolization Market Overview
  • 26.2. South America Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vascular Embolization Market

  • 27.1. Brazil Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vascular Embolization Market

  • 28.1. Middle East Vascular Embolization Market Overview
  • 28.2. Middle East Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vascular Embolization Market

  • 29.1. Africa Vascular Embolization Market Overview
  • 29.2. Africa Vascular Embolization Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Vascular Embolization Market, Segmentation By Embolization Technique, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Vascular Embolization Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vascular Embolization Market Competitive Landscape And Company Profiles

  • 30.1. Vascular Embolization Market Competitive Landscape
  • 30.2. Vascular Embolization Market Company Profiles
    • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck Group Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Vascular Embolization Market Other Major And Innovative Companies

  • 31.1. B. Braun Melsungen AG
  • 31.2. Kaneka Corporation
  • 31.3. Terumo Corporation
  • 31.4. W. L. Gore & Associates Inc.
  • 31.5. Teleflex Inc.
  • 31.6. Cook Group Incorporated
  • 31.7. Merit Medical Systems Inc.
  • 31.8. Penumbra Inc.
  • 31.9. MicroPort Scientific Corporation
  • 31.10. MicroVention Inc.
  • 31.11. Medikit Co Ltd.
  • 31.12. Silk Road Medical Inc.
  • 31.13. Galt Medical Corporation
  • 31.14. Neuravi Ltd.
  • 31.15. Phenox GmbH

32. Global Vascular Embolization Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vascular Embolization Market

34. Recent Developments In The Vascular Embolization Market

35. Vascular Embolization Market High Potential Countries, Segments and Strategies

  • 35.1 Vascular Embolization Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Vascular Embolization Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Vascular Embolization Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer